Author:
He Dongjie,Wu Peiwen,Li Gaiyan,Zhu Siying,Wang Qiming,Shao Qiuju,Chang Hao
Subject
Physiology (medical),Neurology (clinical),Neurology,General Medicine,Surgery
Reference35 articles.
1. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Cao;Chin Med J (Engl),2021
2. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008;Donin;Cancer,2016
3. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 2014;16:iv1–63. https://doi.org/10/gj3td6.
4. Current FDA-approved therapies for high-grade malignant gliomas;Fisher;Biomedicines,2021
5. Comparison of dosimetric gains provided by intensity-modulated radiotherapy, volume-modulated arc therapy, and helical tomotherapy for high-grade glioma;Liu;Biomed Res Int,2020